Company attributes
Other attributes
VWR International is a company offering laboratory products, services, and solutions for global life science, advanced technologies, and research industries that is headquartered in Radnor, Pennsylvania and was founded in 1852. The company also offers custom manufacturing services for liquid manufacturing, liquid dosing and packaging, powder manufacturing, dosing and packaging, and assembly and finishing.
On May 5, 2017 VWR International announced it will be acquired by Avantor Performance Materials for $6.5 billion in cash. The acquisition was completed on November 21, 2017.
On October 7, 2015 VWR International acquired Purification Technologies, a company making solvents for purification and packaging, for an undisclosed amount of money. The president and CEO of VWR International, Manuel Brocke-Benz, made the following statements regarding the company's acquisition of Purification Technologies:
Our customers in the chromatography, biochemical and agrochemical industries will benefit through VWR's ability to supply high purity Acetonitrile and other solvents in both bulk and lab scale quantities. PTI's solvent purification expertise and process capabilities improve access to a key solvent line, and enhance our portfolio of high purity products available to our customers.
On July 5, 2016 VWR International acquired PAW BioScience Products, a company manufacturing and distributing sanitary fluid handling products, for an undisclosed amount of money.
On November 13, 2016 VWR International acquired BioArra, a company making serum-based products for cellular science, for an undisclosed amount of money.
On January 12, 2017 VWR International acquired Seastar Chemicals, a high purity reagent manufacturing company, for an undisclosed amount of money.
On March 22, 2017 VWR International acquired EPL Archives, a company consolidating, preservation, and management of regulated research manufacturing material, for an undisclosed amount of money.
On April 7, 2017 VWR International acquired MESM, a company making laboratory, medical equipment, and ancillary supplies for clinical trials, for an undisclosed amount of funding. The President and CEO of VWR International, Manuel Brocke-Benz, made the following public statement about the company's acquisition of MESM:
MESM is recognized and valued by many of the world's largest pharmaceutical customers and contract research organizations, including a number of existing VWR customers who currently procure our clinical trial and biorepository services. Their focus on equipment supply and excellence in supply chain further complements VWR's growing service offering as a part of VWRCATALYST, allowing us to better serve our customers in achieving their goals by providing end-to-end product and supply chain solutions.
